Mathes Company’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-1,600
| Closed | -$223K | – | 138 |
|
|
2016
Q1 | $223K | Hold |
1,600
| – | – | 0.13% | 118 |
|
|
2015
Q4 | $305K | Hold |
1,600
| – | – | 0.17% | 111 |
|
|
2015
Q3 | $250K | Hold |
1,600
| – | – | 0.17% | 113 |
|
|
2015
Q2 | $289K | Hold |
1,600
| – | – | 0.15% | 127 |
|
|
2015
Q1 | $277K | Hold |
1,600
| – | – | 0.14% | 139 |
|
|
2014
Q4 | $296K | Hold |
1,600
| – | – | 0.15% | 137 |
|
|
2014
Q3 | $265K | Hold |
1,600
| – | – | 0.13% | 144 |
|
|
2014
Q2 | $250K | Hold |
1,600
| – | – | 0.12% | 155 |
|
|
2014
Q1 | $243K | Hold |
1,600
| – | – | 0.13% | 152 |
|
|
2013
Q4 | $213K | Buy |
+1,600
| New | +$213K | 0.11% | 155 |
|